Substance / Medication

Edrophonium

Overview

Active Ingredient
edrophonium
RxNorm CUI
3752

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Effects of neostigmine or edrophonium on force of contraction when administered at a train-of-four ratio of 0.9 in anesthetized dogs.
Romano Marta, Martin-Flores Manuel, Sakai Daniel M et al. · Vet Anaesth Analg · 2017
PMID: 29066245RCT
Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan Ozlem, White Paul F, Tufanogullari Burcu et al. · Anesth Analg · 2007
PMID: 17312210Observational
Edrophonium provocative testing for the evaluation of upper gastrointestinal hypersensitivity in patients with nonulcer dyspepsia.
Tsutsui Shinichi, Mine Kazunori, Handa Masanori et al. · Dig Dis Sci · 2006
PMID: 16868825Observational
A comparison of the chronotropic and dromotropic actions between adenosine triphosphate and edrophonium in patients undergoing coronary artery bypass graft surgery.
Watanabe Seiji, Kono Yasuo, Oishi-Tobinaga Yoko et al. · J Cardiothorac Vasc Anesth · 2002
PMID: 12407613Observational
Which is better in children: edrophonium or neostigmine?
Driessen J J, Robertson E N, Booij L H · Br J Anaesth · 2000
PMID: 10743474Observational
[A case of Miller Fisher syndrome with a false-positive edrophonium test].
Yonemoto Kosuke, Nomura Shunichi, Shimizu Ai et al. · Rinsho Shinkeigaku · 2019
PMID: 31142707Case Report
Detectable voice change with the edrophonium test in laryngeal myasthenia gravis.
Tsunoda Koichi, Fujimaki Yoko, Morita Yoko · J Int Med Res · 2017
PMID: 28379106Case ReportFull text (PMC)
Dropped head with positive intravenous edrophonium, progressing to myasthenia gravis.
Sawa Nobuhiro, Kataoka Hiroshi, Eura Nobuyuki et al. · BMJ Case Rep · 2013
PMID: 23376659Case ReportFull text (PMC)
Upper eyelid retraction disclosed after edrophonium chloride administration in a patient with Graves' orbitopathy and myasthenia gravis.
Kang Hyera, Takahashi Yasuhiro, Iwaki Masayoshi et al. · Clin Ophthalmol · 2012
PMID: 22701081Case ReportFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Edrophonium (substance)
SNOMED CT
373342004
UMLS CUI
C0013615
RxNorm CUI
3752

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.